CN Patent

CN114401724B — 一种降糖药物组合物

Assigned to Shenzhen Salubris Pharmaceuticals Co Ltd · Expires 2024-05-24 · 2y expired

What this patent protects

一种化合物A（结构式如下式I）和/或其药学上可接受的盐与二甲双胍和/或其药学上可接受的盐的降糖药物组合物，该药物组合物可以实现降糖协同作用。

USPTO Abstract

一种化合物A（结构式如下式I）和/或其药学上可接受的盐与二甲双胍和/或其药学上可接受的盐的降糖药物组合物，该药物组合物可以实现降糖协同作用。

Drugs covered by this patent

minocycline-hydrochloride (MINOCYCLINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN114401724B
Jurisdiction: CN
Classification: —
Expires: 2024-05-24
Drug substance claim: No
Drug product claim: No
Assignee: Shenzhen Salubris Pharmaceuticals Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.